CVS Health Corp (N:CVS)

Business Focus: Healthcare Facilities & Services

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 1 Cvs Dr
WOONSOCKET RI 02895-6146
Tel: N/A
Website: https://www.cvshealth.com
IR: See website
<
Key People
David Wyatt Dorman
Independent Chairman of the Board
James D. Clark
Senior Vice President, Chief Accounting Officer, Controller
Larry J. Merlo
President, Chief Executive Officer, Director
Eva C. Boratto
Chief Financial Officer, Executive Vice President
Kevin Hourican
President of CVS Pharmacy
Derica W. Rice
President - CVS Caremark
Jonathan C. Roberts
Chief Operating Officer, Executive Vice President
Lisa G. Bisaccia
Chief Human Resource Officer, Executive Vice President
Thomas M. Moriarty
Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
Troyen A. Brennan
Executive Vice President, Chief Medical Officer
   
Business Overview
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.
Financial Overview
For the fiscal year ended 31 December 2018, CVS Health Corp revenues increased 5% to $194.58B. Net loss applicable to common stockholders excluding extraordinary items totaled $697M vs. income of $5.11B. Revenues reflect Retail Pharmacy Segment increase of 6% to $83.99B, Pharmacy Services Segment increase of 3% to $134.13B, Comp. Store Sales (Growth - %) - Pharmay increase from -2.6 to 7.9%.
Employees: 295,000 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $139,692M as of Dec 31, 2018
Annual revenue (TTM): $194,579M as of Dec 31, 2018
EBITDA (TTM): $12,888M as of Dec 31, 2018
Net annual income (TTM): -$698.00M as of Dec 31, 2018
Free cash flow (TTM): $4,790M as of Dec 31, 2018
Net Debt Last Fiscal Year: $66,848M as of Dec 31, 2018
Shares outstanding: 1,297,082,165 as of Feb 19, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization